ArticleBMC public health2022
Medicines and vaccines supply chains challenges in Nigeria: a scoping review.
Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.
- Integrated maternal, newborn and child-health strategies and interventions for reducing maternal and child mortality in Nigeria: a systematic review.BMC public health · 2026Pooled it
- Wings of access: a cluster RCT on drone-based medical commodity delivery in remote Madagascar.BMJ global health · 2026Trial
- Childhood immunization barriers and interventions in low- and middle-income countries: A scoping review of access, delivery systems, and health literacy.Human vaccines & immunotherapeutics · 2026Article
- Exploring the potential of mRNA vaccines in combatting communicable and non-communicable diseases in low-income and lower-middle-income countries.Annals of medicine and surgery (2012) · 2026Review
- Improving medication availability through mobile wallets and pooled community funds: results from the MoPuleesa hypertension intervention in rural Uganda.Health policy and planning · 2026Article
- Challenges and best practices in essential medicines supply and use in internally displaced persons (IDP) camps: A qualitative study.Exploratory research in clinical and social pharmacy · 2026Article
- Catalysing vaccines research, development and manufacturing in Nigeria: a qualitative exploration of industry stakeholders' knowledge, perceptions and experience.Health research policy and systems · 2026Article
- Capacity and site readiness for hypertension control program implementation in Nigeria: A nationwide cross-sectional study.PloS one · 2026Article
- Supply chain management of health commodities and essential drug procurement systems at Sankhuwasabha and Kavrepalanchowk districts of federal Nepal.Journal of public health research · 2026Article
- A qualitative exploration of critical issues limiting local vaccines production in Nigeria: lessons from the COVID-19 pandemic.BMC public health · 2025Article
- Co-creating systems change for mental health: a theory of change approach from the MeHPriC initiative in Lagos, Nigeria.Implementation science communications · 2025Article
- Factors contributing to human and veterinary medicine shortages in developing countries: perspectives of suppliers and regulators in Namibia.Tropical medicine and health · 2025Article
- Availability of essential medicines, inventory management practices, and related challenges in internally displaced persons (IDP) camps, eastern Amhara, Ethiopia: an explanatory sequential mixed study.Conflict and health · 2025Article
- Effects of climate change on vaccine storage and cold chain logistics: a qualitative study in Ogun State, Nigeria.BMJ global health · 2025Article
- Applying a Theory of Change for Human Resources Development in Public Health Supply Chains in Rwanda.Global health, science and practice · 2025Article
- Promising Practices in Capacity Development for Health Supply Chains in Resource-Constrained Countries.Global health, science and practice · 2025Review
- Establishing Sustainable Access to Quality Uterotonics in Kano, Lagos and Niger States-A Supply Chain Perspective.The International journal of health planning and management · 2025Article
- Community pharmacy workforce willingness, readiness, and infrastructural capacity to deliver vaccination services: a cross-sectional survey in Nigeria.BMC health services research · 2025Article
- Public sector pharmaceutical distribution system and its challenges: a case of a central Ethiopian Pharmaceuticals Supply Service and selected branches.BMC health services research · 2025Article
- Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedicines and vaccines supply chains represent critical systems for realising one of the major targets of the United Nations' third Sustainable Development Goals (SDGs)-access to safe, effective, quality, and affordable essential medicines and vaccines, for all. However, evidence suggests the system is confronted with several challenges in many low-medium income countries, including Nigeria. This scoping review aims to summarize the available evidence on the challenges of medicines and vaccines supply chain system in Nigeria.
resultsWe searched relevant databases including Scopus and Web of Science for studies published between January 2005 and August 2020 on the challenges associated with medicines and vaccines supply chain systems in Nigeria. Our findings implicate several factors including difficulty with medicines or vaccines selection, procurement, distribution, and inventory management. Others included poor storage infrastructure, financial constraints, insecurity, transportation challenges, inadequate human resources, weak, or poorly implemented policies. These challenges mostly resulted in stock-outs of essential medicines which notably got worsened during the current COVID-19 pandemic.
conclusionOur study is a wake-up call on the need to prioritise the critical sector of the supply chain systems for medicines and vaccines in Nigeria. Effective implementation of existing policies, improved security, strengthening of the health system through adequate budgetary allocations, and provision of infrastructure including regular availability of electricity are keys to surmounting the challenges and improving access to medicines or vaccines in Nigeria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.